BioCentury | Jul 19, 1999
Company News

NeoPath, Bayer Diagnostics deal

...expect to produce a preclinical prototype, for which Bayer will fund development, by year end. NeoPath Inc....
BioCentury | Dec 9, 1996
Clinical News

NeoPath regulatory update

...method that uses image-processing computers to identify Pap smears with the highest potential for abnormality. NeoPath Inc....
BioCentury | Sep 9, 1996
Clinical News

NeoPath regulatory update

...its AutoPap 300 QC System, a device for rescreening microscopic images from Pap smear slides. NeoPath Inc....
BioCentury | Sep 3, 1996
Clinical News

NeoPath regulatory update

...review NPTH's PMA for its AutoPap System as a primary screener of Pap smear slides. NeoPath Inc....
BioCentury | Jul 22, 1996
Clinical News

NeoPath regulatory update

...slides. The FDA approved the product last September for quality control rescreening of the slides. NeoPath Inc....
BioCentury | Jul 22, 1996
Company News

NeoPath, Neuromedical Systems Inc. reproductive news

...its AutoPap system, which is used in the quality control rescreening of pap smear slides. NeoPath Inc....
BioCentury | Jul 8, 1996
Company News

NeoPath, Nikon Corp. sales and marketing update

...maintenance, repair and other service, while NPTH will provide Nikon with technical support and training. NeoPath Inc....
BioCentury | Jul 1, 1996
Company News

NeoPath, Laboratory Corp. of America Holdings sales and marketing update

...rescreens Pap smear slides initially classified as normal in order to detect potential missed abnormality. NeoPath Inc....
BioCentury | Jan 8, 1996
Finance

The Buyside View, IV

...therapy), Vivus Inc. (VVUS, Menlo Park, Calif., in reproductive), Focal Inc. (Lexington, Mass., in biomaterials), NeoPath Inc....
Items per page:
1 - 9 of 9
BioCentury | Jul 19, 1999
Company News

NeoPath, Bayer Diagnostics deal

...expect to produce a preclinical prototype, for which Bayer will fund development, by year end. NeoPath Inc....
BioCentury | Dec 9, 1996
Clinical News

NeoPath regulatory update

...method that uses image-processing computers to identify Pap smears with the highest potential for abnormality. NeoPath Inc....
BioCentury | Sep 9, 1996
Clinical News

NeoPath regulatory update

...its AutoPap 300 QC System, a device for rescreening microscopic images from Pap smear slides. NeoPath Inc....
BioCentury | Sep 3, 1996
Clinical News

NeoPath regulatory update

...review NPTH's PMA for its AutoPap System as a primary screener of Pap smear slides. NeoPath Inc....
BioCentury | Jul 22, 1996
Clinical News

NeoPath regulatory update

...slides. The FDA approved the product last September for quality control rescreening of the slides. NeoPath Inc....
BioCentury | Jul 22, 1996
Company News

NeoPath, Neuromedical Systems Inc. reproductive news

...its AutoPap system, which is used in the quality control rescreening of pap smear slides. NeoPath Inc....
BioCentury | Jul 8, 1996
Company News

NeoPath, Nikon Corp. sales and marketing update

...maintenance, repair and other service, while NPTH will provide Nikon with technical support and training. NeoPath Inc....
BioCentury | Jul 1, 1996
Company News

NeoPath, Laboratory Corp. of America Holdings sales and marketing update

...rescreens Pap smear slides initially classified as normal in order to detect potential missed abnormality. NeoPath Inc....
BioCentury | Jan 8, 1996
Finance

The Buyside View, IV

...therapy), Vivus Inc. (VVUS, Menlo Park, Calif., in reproductive), Focal Inc. (Lexington, Mass., in biomaterials), NeoPath Inc....
Items per page:
1 - 9 of 9